Tsunetoh Satoshi 恒遠啓示

… Alternative Names

Researcher Number	70388255
Affiliation (Current)	2020: 大阪医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2015 – 2020: 大阪医科大学, 医学部, 講師 2017: 大阪医科大学, 医学部, 助手 2012 – 2015: 大阪医科大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Obstetrics and gynecology Except Principal Investigator Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related
Keywords	Principal Investigator EMT / 明細胞腺癌 / CD24 / MET / Met / BNCT / 子宮頸癌 / 子宮頸がん / 硼素化合物 / 硼素内包高分子ミセル … More Except Principal Investigator … More

3次元オルガノイド培養を用いた難治性卵巣癌の個別化医療の構築Ongoing
- Principal Investigator
  
  大道正英
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical College
Analysis of extracellular vesicles using patient derived xenograftOngoing
- Principal Investigator
  
  田中智人
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical College
エリブリンによる腫瘍免疫を介した難治性卵巣癌に対する新たな治療戦略Ongoing
- Principal Investigator
  
  藤原聡枝
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical College
Research for cancer microenvironment via FABP4 in endometrial cnacer
- Principal Investigator
  
  Sasaki Hiroshi
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Development of a new therapy for refractory ovarian cancer via liposomal nanoparticle targeting control of EMT
- Principal Investigator
  
  Ohmichi Masahide
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Treatment strategy of boron neutron capture therapy in cervical cancerPrincipal Investigator
- Principal Investigator
  
  Tsunetoh Satoshi
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
A novel miRNA regulates the EMT and MMT of peritoneal mesothelium in ovarian cancer
- Principal Investigator
  
  Terai Yoshito
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Kobe University
  Osaka Medical College
activation regulatory mechanism of cancer fibroblast by obesity
- Principal Investigator
  
  Takai Masaaki
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Analysis of lipid raft via CD24 and drug resistance in gynecologic cancer
- Principal Investigator
  
  Tanaka Yoshimichi
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Testosterone for the Prevention of Cyclophosphamide -Induced Ovarian Toxicity
- Principal Investigator
  
  Tanabe Akiko
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancer
- Principal Investigator
  
  Fujiwara Satoe
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
The elucidation of the mechanism in cancer microenvironment by ovarian cancer secretion exosome and the development of a next-generation cancer therapy by the exosome.
- Principal Investigator
  
  SASAKI HIROSHI
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Potential therapeutic target of microRNA in cervical cancer.
- Principal Investigator
  
  Masami Hayashi
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Elucidation of novel molecules involved in the MET and disseminated in ovarian cancer peritoneal metastasis
- Principal Investigator
  
  KANEMURA MASANORI
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
CD24-targeting drug delivery system enhanced effect of cisplatin-resistant ovarian cancer cells
- Principal Investigator
  
  TERAI YOSHITO
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Development of anticancer drug resistance evaluation system, and early recurrence-detection tools in ovarian cancer
- Principal Investigator
  
  Ohmichi Masahide
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
To control in invasion and metastasis through EMT (Epithelial-Mesenchymal-Transition) functional analysis of CD24 in endometrial cancer
- Principal Investigator
  
  OHMICHI Masahide
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Control of EMT phenomenon by mTOR inhiibitor for ovarian clear cell carcinoma.Principal Investigator
- Principal Investigator
  
  TSUNETOH Satoshi
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College

All 2019 2018 2017 2015 2014 2013 Other

All Journal Article Presentation

[Journal Article] Intraperitoneal cytology after laparoscopic radical hysterectomy with vaginal closure without the use of a manipulator for cervical cancer: a retrospective observational study2019
- Author(s)
  Tanaka T, Miyamoto S, Terada S, Kogata Y, Sasaki H, Tsunetoh S, Yamada T, Ohmichi M
- Journal Title
  
  Cancer Manag Res.
  
  Volume: 11 Pages: 7015-7020
- DOI
  10.2147/cmar.s210277
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09838
[Journal Article] A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma2018
- Author(s)
  Maeda Kazuya、Terai Yoshito、Terada Shinichi、Maruoka Hiroshi、Kogata Yuhei、Ashihara Keisuke、Tanaka Yoshimichi、Tanaka Tomohito、Sasaki Hiroshi、Tsunetoh Satoshi、Yamada Takashi、Ohmichi Masahide
- Journal Title
  
  Journal of Ovarian Research
  
  Volume: 11 Pages: 74-74
- DOI
  10.1186/s13048-018-0446-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K11165
[Journal Article] The efficacy of the cyclin-dependent kinase 4/6 inhibitor in endometrial cancer.2017
- Author(s)
  anaka T, Terai Y, Ashihara K, Fujiwara S, Tanaka Y, Sasaki H, Tsunetoh S, Ohmichi M
- Journal Title
  
  PLoS One
  
  Volume: 12
- DOI
  10.1371/journal.pone.0177019
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26462541
[Journal Article] CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways2017
- Author(s)
  Nakamura K, Terai Y, Tanabe A, Ono YJ, Hayashi M, Maeda K, Fujiwara S, Ashihara K, Nakamura M, Tanaka Y, Tanaka T, Tsunetoh S, Sasaki H, Ohmichi M.
- Journal Title
  
  Oncology Reports
  
  Volume: - Pages: 3189-3200
- DOI
  10.3892/or.2017.5583
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26462541, KAKENHI-PROJECT-16K11162, KAKENHI-PROJECT-16K11165, KAKENHI-PROJECT-17K11304
[Journal Article] CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer.2015
- Author(s)
  Tanaka T, Terai Y, Kogata Y, Ashihara K, Maeda K, Fujiwara S, Yoo S, Tanaka Y, Tsunetoh S, Sasaki H, Kanemura M, Tanabe A, Ohmichi M.
- Journal Title
  
  Oncology Reports
  
  Volume: 34 Pages: 2282-2288
- DOI
  10.3892/or.2015.4257
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25670709
[Journal Article] The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer.2014
- Author(s)
  Takai M, Terai Y, Kawaguchi H, Ashihara K, Fujiwara S, Tanaka T, Tsunetoh S, Tanaka Y, Sasaki H, Kanemura M, Tanabe A, Ohmichi M.
- Journal Title
  
  J Ovarian Res
  
  Volume: 76 Pages: 1-5
- DOI
  10.1186/1757-2215-7-76
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24592536, KAKENHI-PROJECT-25670709, KAKENHI-PROJECT-26462541
[Journal Article] Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.2014
- Author(s)
  Kawaguchi H, Terai Y, Tanabe A, Sasaki H, Takai M, Fujiwara S, Ashihara K, Tanaka Y, Tanaka T, Tsunetoh S, Kanemura M, Ohmichi M.
- Journal Title
  
  J Ovarian Res
  
  Volume: 7 Pages: 38-38
- DOI
  10.1186/1757-2215-7-38
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25670709, KAKENHI-PROJECT-26462541
[Journal Article] Prognostic impact of EMT (epithelial-mesenchymal-transition)-relatedprotein expression in endometrial cancer.2013
- Author(s)
  Yoshimichi Tanaka, Yoshito Terai, Hiroshi Kawaguchi, Satoe Fujiwara, Saha Yoo, Satosi Tsunetoh, Masaaki Takai, Masanori Kanemura, Akiko Tanabe, Masahide Ohmichi
- Journal Title
  
  Cancer Biology and Therapy
  
  Volume: 14 Pages: 13-16
- Data Source
  KAKENHI-PROJECT-25670709
[Journal Article] Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer.2013
- Author(s)
  Yoshimichi Tanaka
- Journal Title
  
  Cancer biology and therapy
  
  Volume: 14(1) Pages: 13-16
- DOI
  10.4161/cbt.22625
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591869, KAKENHI-PROJECT-24390384
[Presentation] GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancer2018
- Author(s)
  藤原聡枝　田中良道　田中智人　恒遠啓示　佐々木浩　寺井義人　大道正英
- Organizer
  International Gynecologic Cancer Society 2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K10738
[Presentation] 難治性卵巣癌モデルマウスに対するCD24を標的とした高分子ミセルを用いた新規治療2017
- Author(s)
  芦原敬允, 寺井義人, 土橋裕允, 藤原聡枝, 田中良道, 田中智人, 恒遠啓示, 佐々木浩, 林正美, 大道正英
- Organizer
  第69回日本産科婦人科学会学術集会
- Data Source
  KAKENHI-PROJECT-17K11304
[Presentation] シスプラチン内包CD24高分子ミセルを用いた難治性卵巣癌モデルへの治療応用2015
- Author(s)
  芦原敬允、寺井義人、古形祐平、藤田和也、小野賀大、藤原聡枝、田中良道、田中智人、佐々木浩、恒遠啓示、金村昌徳、田辺晃子、大道正英
- Organizer
  第14回日本婦人科がん分子標的研究会
- Place of Presentation
  美ヶ原温泉ホテル翔峰
- Year and Date
  2015-07-17
- Data Source
  KAKENHI-PROJECT-25670709
[Presentation] シスプラチン内包CD24高分子ミセルの開発とマウス難治性卵巣癌モデルへの治療応用2015
- Author(s)
  芦原　敬允、田中　良道、田中　智人、佐々木　浩、恒遠　啓示、田辺　晃子、金村　昌徳、寺井　義人、大道　正英
- Organizer
  第67回日本産科婦人科学会
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2015-04-09
- Data Source
  KAKENHI-PROJECT-25670709
[Presentation] シスプラチン内包CD24高分子ミセルを用いた難治性卵巣癌モデルへの治療応用2015
- Author(s)
  芦原敬允、寺井義人、古形祐平、藤田和也、小野賀大、藤原聡枝、田中良道、田中智人、佐々木浩、恒遠啓示、金村昌徳、田辺晃子、大道正英
- Organizer
  第14回日本婦人科がん分子標的研究会
- Place of Presentation
  松本市
- Year and Date
  2015-07-18
- Data Source
  KAKENHI-PROJECT-25462621
[Presentation] 卵巣癌におけるEMT現象の意義2013
- Author(s)
  高井雅聡、寺井義人、川口浩史、中村路彦、兪史夏、藤原聡枝、田中智人、田中良道、恒遠啓示、田辺晃子、金村昌徳、大道正英
- Organizer
  第53回日本婦人科腫瘍学会
- Place of Presentation
  岡山コンベンションセンター
- Data Source
  KAKENHI-PROJECT-24592536
[Presentation] 白金製剤耐性卵巣癌におけるAktをターゲットとした分子標的薬としてのGemicitabineの機能解析2013
- Author(s)
  川口浩史、寺井義人、恒遠啓示、佐々木浩、高井雅聡、兪史夏、藤原聡枝、田中智人、田中良道、田辺晃子、金村昌徳、大道正英
- Organizer
  第53回日本婦人科腫瘍学会
- Place of Presentation
  岡山コンベンションセンター
- Data Source
  KAKENHI-PROJECT-24592536
[Presentation] 若年性子宮内膜癌・子宮内膜異形増殖症に対するMPA治療法の治療成績2013
- Author(s)
  田中良道、川口浩史、高井雅聡、兪　史夏、藤原聡枝、田中智人、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  第51回日本癌治療学会
- Place of Presentation
  京都　京都国際会館
- Data Source
  KAKENHI-PROJECT-24390384
[Presentation] 上皮間葉転換を介した浸潤・転移の制御を目指して2013
- Author(s)
  中村起代子、田中良道、川口浩史、高井雅聡、兪　史夏、藤原聡枝、田中智人、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  第65回日本産科婦人科学会
- Place of Presentation
  北海道　ロイトン札幌
- Data Source
  KAKENHI-PROJECT-24390384
[Presentation] 上皮間葉転換(EMT)を介した浸潤・転移の制御を目指して　～CD24の機能解析～2013
- Author(s)
  中村起代子、田中良道、川口浩史、高井雅聡、兪史夏、藤原聡枝、田中智人、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  第53回日本婦人科腫瘍学会
- Place of Presentation
  岡山コンベンションセンター
- Data Source
  KAKENHI-PROJECT-24592536
[Presentation] 上皮間葉転換(EMT)を介した浸潤・転移の制御を目指して～CD24の機能解析～2013
- Author(s)
  中村起代子、田中良道、川口浩史、高井雅聡、兪　史夏、藤原聡枝、田中智人、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  第６５回日本産科婦人科学会
- Place of Presentation
  北海道　ロイトン札幌
- Data Source
  KAKENHI-PROJECT-25670709
[Presentation] 卵巣癌におけるCD24の発現意義と機能解析について
- Author(s)
  芦原敬允、田中良道、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  第66回日本産科婦人科学会
- Place of Presentation
  東京都　東京国際フォーラム
- Year and Date
  2014-04-18 – 2014-04-20
- Data Source
  KAKENHI-PROJECT-25670709
[Presentation] 卵巣癌におけるCD24の発現意義と機能解析について
- Author(s)
  芦原敬允、寺井義人、藤原聡枝、田中良道、恒遠啓示、田辺晃子、金村昌徳、大道正英
- Organizer
  日本婦人科癌分子標的研究会
- Place of Presentation
  東京国際フォーラム
- Year and Date
  2014-04-18 – 2014-04-20
- Data Source
  KAKENHI-PROJECT-24390384
[Presentation] Epithelial Mesenchymal Transition (EMT) in Endometrial Cancer
- Author(s)
  Tanaka Y, Terai Y, Fujiwara S, Tsunetoh S, Kanemura M, Tanabe A, Ohmichi M.
- Organizer
  第3回アジア婦人科腫瘍学会　第55回日本婦人科腫瘍学会
- Place of Presentation
  ウェスティン都ホテル京都
- Year and Date
  2014-12-13 – 2014-12-15
- Data Source
  KAKENHI-PROJECT-24390384
[Presentation] 卵巣癌におけるCD24の発現意義と機能解析について
- Author(s)
  芦原敬允、中村起代子、中村路彦、兪史夏、田中良道、田中智人、佐々木浩、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  日本産科婦人科学会
- Place of Presentation
  東京国際フォーラム
- Year and Date
  2014-04-18 – 2014-04-20
- Data Source
  KAKENHI-PROJECT-24592536

1. OHMICHI Masahide (10283764)

# of Collaborated Projects: 18 results

# of Collaborated Products: 24 results
2. TANAKA Yoshimichi (10625502)

# of Collaborated Projects: 17 results

# of Collaborated Products: 24 results
3. TERAI Yoshito (90278531)

# of Collaborated Projects: 17 results

# of Collaborated Products: 23 results
4. HAYASHI Masami (00551748)

# of Collaborated Projects: 16 results

# of Collaborated Products: 2 results
5. TANABE Akiko (70454543)

# of Collaborated Projects: 14 results

# of Collaborated Products: 19 results
6. SASAKI HIROSHI (80432491)

# of Collaborated Projects: 12 results

# of Collaborated Products: 8 results
7. Fujiwara Satoe (90707960)

# of Collaborated Projects: 10 results

# of Collaborated Products: 4 results
8. KANEMURA Masanori (40298782)

# of Collaborated Projects: 9 results

# of Collaborated Products: 18 results
9. Yoo Saha (80625674)

# of Collaborated Projects: 8 results

# of Collaborated Products: 3 results
10. 田中智人 (90411363)

# of Collaborated Projects: 6 results

# of Collaborated Products: 1 results
11. YAMASHITA Yoshiki (50268207)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
12. 古形祐平 (80829953)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
13. YAMADA Takashi (10182536)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. ASAHI Michio (10397614)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. Takai Masaaki (90770933)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. NAKAMURA Kiyoko

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results

Tsunetoh Satoshi 恒遠 啓示

TSUNETOH Satoshi 恒遠 啓示

Research Projects

Research Products

Co-Researchers

3次元オルガノイド培養を用いた難治性卵巣癌の個別化医療の構築Ongoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Analysis of extracellular vesicles using patient derived xenograftOngoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

エリブリンによる腫瘍免疫を介した難治性卵巣癌に対する新たな治療戦略Ongoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Treatment strategy of boron neutron capture therapy in cervical cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Tsunetoh Satoshi 恒遠啓示

TSUNETOH Satoshi 恒遠啓示